Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees
May 18 (Reuters) - Strides Pharma Science Ltd SRID.NS: STRIDES PHARMA SCIENCE MARCH-QUARTER CONSOL NET PROFIT 1.27 BILLION RUPEES STRIDES PHARMA SCIENCE MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 13.23 BILLION RUPEES STRIDES PHARMA SCIENCE LTD - RECOMMENDS FINAL DIVIDEND OF 5 RUPEES PER SHARE FOR FY2026 Source text: ID:nnAZN4SWWQY Further company coverage: SRID.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees